Parenteral Drugs (PDPL) Experts Views (BUY SELL) [2024] (PDPL) share price target ["experts views"] BUY/SELL -NSE stock exchange

Parenteral Drugs PDPL Experts view BUY SELL, share price targets for short, mid, long term 2024 NSE stock exchange

NSE stock PDPL Parenteral Drugs experts views & buy sell levels signals are here. Parenteral Drugs forecast & share price targets are here or Parenteral Drugs share price targets and PDPL Parenteral Drugs tomorrow's movements predictions are here or Announcements & NEWS by Parenteral Drugs

Stock listed under Pharmaceuticals

Parenteral Drugs share price opened at: 3.80
Parenteral Drugs share price closed at: 3.80
Parenteral Drugs share price made a High of: 3.80
Parenteral Drugs share price made a low of: 3.80

Detailed analysis of what to do in Intraday & BTST tips for Parenteral Drugs are here
52 week High of Parenteral Drugs: 28.80
52 week Low of Parenteral Drugs: 2.50
PDPL is trading in the lower range of yearly prices.

Went as high as 3.80 in the last three months (quarter)
Went as low as 3.80 in the last three months (quarter)
PDPL is trading in the lower range of the quarterly prices.

The session was a neutral tug of war session and prices moved within a range of 3.80 and 3.80, with a volume of 33.61% compared to average volume that Parenteral Drugs normally has.

The NSE share PDPL Parenteral Drugs appears to be moving upwards constantly. Keep reading experts views on Parenteral Drugs below for shortterm to longterm PDPL share prices targets and buy sell signals, points & levels.

NSE PDPL Experts Views Parenteral Drugs Buy Sell Signals

The share prices have been rising up shortly. An initial buy or sell signal has not been generated yet. However, if a BUY/SELL signal is mentioned below then you can choose to take a trade with a strict stoploss.

NSE PDPL Experts Views Parenteral Drugs MACD Convergence Divergence

Parenteral Drugs fast MACD line is above the slow signal MACD line, but in dead cross zone, negative zone

Both the lines are diverging, going away from each other, with a difference of 0.18
A BUY signal was generated earlier, and the stock might soon pick more momentum, or might test a resistance level. Use your trailing stoploss if you already have a position. Bookmark this page for future updates.

NSE PDPL Parenteral Drugs experts views on Support & Resistance

These support and resistance levels of PDPL are derived based on analysis of an entire years daily closing prices. These are all extremely strong levels to watch in Parenteral Drugs

Levels to watch:

Parenteral Drugs has strong support or resistance at 5, 6, 7, 8, 9, 10, 11, 13
The current share price is 3.80

Parenteral Drugs PDPL share price targets

Levels of 3.56, 3.91, 5.1, 6.37, 8.05 are share price targets for Parenteral Drugs PDPL Click here for weekly and monthly share price targets

Downside intraday target	3.56
Upside intraday target	3.91
Upside short term target	5.1
Upside mid term target	6.37
Upside long term target	8.05

Experts also view these below mentioned levels as important because Parenteral Drugs has been reversing its trend at these levels. These levels below are derived by analysing one year charts of Parenteral Drugs

Important support & resistance levels of PDPL are 3.47, 6.37, 8.05, 10.94, 19.36, 23.57. Experts view is that the stock of Parenteral Drugs might change its trend at one of these levels.

Whether these targets will be achieved or not will depend on the trend of Parenteral Drugs. See the Convergence & Divergence section above to understand the trend of NSE share Parenteral Drugs. You can also check Future Forecast & Targets for Parenteral Drugs or Parenteral Drugs share price targets or Tomorrow's predictions for Parenteral Drugs

NSE share PDPL experts views on candles stick analysis of Parenteral Drugs

Daily candle stick experts view of NSE share Parenteral Drugs

Latest Parenteral Drugs candle has no body and might be a doji. Read below.
High made is 0% above the candle
Parenteral Drugs share price high is about 0% of the candle stick body.
Parenteral Drugs share price Low made is 0% below candle
Low share price is about 0% of the candle stick body.

The prices did not move up or down by the end of the session. Experts view is that this might be a doji candle stick. Wait, Let me check...

Previous candle has no body and might be a doji. Still undecisive.

Two candles back candle stick is a bullish candle, with a length of 0%

Weekly candle stick experts view of NSE share Parenteral Drugs

Latest Parenteral Drugs candle stick is a bullish candle, with a length of 8.57%
High made is about 0% above the closing.
Parenteral Drugs share price high is about 0% of the candle stick body.
Parenteral Drugs share price Low made is about 0% below the opening.
Low share price is about 0% of the candle stick body.

Experts view is that the stock showed immediate buying from lower levels in this session.

Previous candle stick is a bullish candle, with a length of 0%

Two candles back candle stick is a bullish candle, with a length of 18%

Monthly candle stick experts view of NSE share Parenteral Drugs

Latest Parenteral Drugs candle stick is a bullish candle, with a length of 52%
High made is about 0% above the closing.
Parenteral Drugs share price high is about 0% of the candle stick body.
Parenteral Drugs share price Low made is about 0% below the opening.
Low share price is about 0% of the candle stick body.

Experts view is that the stock showed immediate buying from lower levels in this session.

Previous candle stick is a bearish candle, with a length of 20.37%

two candles back candle stick is a bearish candle, with a length of 6.77%

View charts of Parenteral Drugs below

Parenteral Drugs share price targets or Parenteral Drugs Support & Resistance Levels

Daily Charts of PDPL , Daily candle stick charts of PDPL, Weekly charts of PDPL , Monthly Charts of PDPL , Moving Averages charts of PDPL , MACD charts of PDPL , or Technical analysis Reports of PDPL , or simply read Tomorrow's predictions of PDPL and Future Forecast & share price targets of Parenteral Drugs or Parenteral Drugs share price targets